Trichomonas vaginalis: Difference between revisions

Line 25: Line 25:


==References==
==References==
 
<references/>
[[Category:OBGYN]]
[[Category:OBGYN]]
[[Category:ID]]
[[Category:ID]]

Revision as of 02:54, 20 August 2016

Background

  • Considered an STI
  • Associated with preterm birth, PID, cervical cancer, increased transmission of other STIs

Clinical Features

  • Yellow, malordorous discharge
  • Vaginal erythema or edema

Differential Diagnosis

Vulvovaginitis

Sexually transmitted diseases

Evaluation

  • Wet mount shows mobile trichomonads

Management

Non-Pregnant

Pregnant

Only treat if the patient is symptomatic

Sexual Partner Treatment

Women with HIV Infection

  • Metronidazole 500 mg PO BID x 7 days[4]

See Also

References

  1. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
  2. CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm
  3. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
  4. CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(No. RR-12)